1. Home
  2. WGSWW vs FISI Comparison

WGSWW vs FISI Comparison

Compare WGSWW & FISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGSWW
  • FISI
  • Stock Information
  • Founded
  • WGSWW 2017
  • FISI 1817
  • Country
  • WGSWW United States
  • FISI United States
  • Employees
  • WGSWW N/A
  • FISI N/A
  • Industry
  • WGSWW Retail: Computer Software & Peripheral Equipment
  • FISI Major Banks
  • Sector
  • WGSWW Technology
  • FISI Finance
  • Exchange
  • WGSWW Nasdaq
  • FISI Nasdaq
  • Market Cap
  • WGSWW N/A
  • FISI N/A
  • IPO Year
  • WGSWW N/A
  • FISI 1999
  • Fundamental
  • Price
  • WGSWW $0.25
  • FISI $28.66
  • Analyst Decision
  • WGSWW
  • FISI Buy
  • Analyst Count
  • WGSWW 0
  • FISI 4
  • Target Price
  • WGSWW N/A
  • FISI $29.75
  • AVG Volume (30 Days)
  • WGSWW 35.4K
  • FISI 160.5K
  • Earning Date
  • WGSWW 02-18-2025
  • FISI 01-30-2025
  • Dividend Yield
  • WGSWW N/A
  • FISI 4.33%
  • EPS Growth
  • WGSWW N/A
  • FISI N/A
  • EPS
  • WGSWW N/A
  • FISI N/A
  • Revenue
  • WGSWW $305,450,000.00
  • FISI $110,758,000.00
  • Revenue This Year
  • WGSWW N/A
  • FISI N/A
  • Revenue Next Year
  • WGSWW N/A
  • FISI $7.80
  • P/E Ratio
  • WGSWW N/A
  • FISI N/A
  • Revenue Growth
  • WGSWW 50.79
  • FISI N/A
  • 52 Week Low
  • WGSWW $0.21
  • FISI $16.29
  • 52 Week High
  • WGSWW $0.25
  • FISI $29.79
  • Technical
  • Relative Strength Index (RSI)
  • WGSWW N/A
  • FISI 56.91
  • Support Level
  • WGSWW N/A
  • FISI $27.22
  • Resistance Level
  • WGSWW N/A
  • FISI $29.79
  • Average True Range (ATR)
  • WGSWW 0.00
  • FISI 0.76
  • MACD
  • WGSWW 0.00
  • FISI 0.12
  • Stochastic Oscillator
  • WGSWW 0.00
  • FISI 66.96

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Share on Social Networks: